PATHOPHYSIOLOGY AND CLONAL EVOLUTION OF MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
Malcovati, L. [1 ,2 ]
机构：
[1] Univ Pavia, Dept Mol Med, Pavia, Italy
[2] IRCCS Fdn Policlin S Matteo, Dept Hematol, Pavia, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
MUTATIONS; HEMATOPOIESIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：187 / 189
页数：3
相关论文
共 50 条
  • [41] KARYOTYPIC EVOLUTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    BENITEZ, J
    CARBONELL, F
    FAYOS, JS
    HEIMPEL, H
    CANCER GENETICS AND CYTOGENETICS, 1985, 16 (02) : 157 - 167
  • [42] Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution
    Svobodova, Karla
    Lhotska, Halka
    Hodanova, Lucie
    Pavlistova, Lenka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Brezinova, Jana
    Sarova, Iveta
    Izakova, Silvia
    Lizcova, Libuse
    Siskova, Magda
    Jonasova, Anna
    Cermak, Jaroslav
    Michalova, Kyra
    Zemanova, Zuzana
    GENES CHROMOSOMES & CANCER, 2020, 59 (07): : 396 - 405
  • [43] Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations
    Lin, Tung-Liang
    Nagata, Yasunobu
    Kao, Hsiao-Wen
    Sanada, Masashi
    Okuno, Yusuke
    Huang, Chein-Fuang
    Liang, Der-Cherng
    Kuo, Ming-Chung
    Lai, Chang-Liang
    Lee, En-Hui
    Shih, Yu-Shu
    Tanaka, Hiroko
    Shiraishi, Yuichi
    Chiba, Kenichi
    Lin, Tung-Huei
    Wu, Jin-Hou
    Miyano, Satoru
    Ogawa, Seishi
    Shih, Lee-Yung
    HAEMATOLOGICA, 2014, 99 (01) : 28 - 36
  • [44] Clonal Evolution Underlying the Progression from Myelodysplastic Syndromes to Ph-Positive Acute Lymphoblastic Leukemia
    Taguchi, Masataka
    Kohno, Tomoko
    Mishima, Hiroyuki
    Taniguchi, Hiroaki
    Kato, Takeharu
    Itonaga, Hidehiro
    Sato, Shinya
    Kinoshita, Akira
    Hata, Tomoko
    Moriuchi, Yukiyoshi
    Yoshiura, Koh-ichiro
    Miyazaki, Yasushi
    BLOOD, 2016, 128 (22)
  • [45] Identification of cryptic aberrations allows more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution
    Svobodova, Karla
    Lhotska, Halka
    Hodanova, Lucie
    Pavlistova, Lenka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Brezinova, Jana
    Sarova, Iveta
    Izakova, Silvia
    Lizcova, Libuse
    Siskova, Magda
    Jonasova, Anna
    Cermak, Jaroslav
    Michalova, Kyra
    Zemanova, Zuzana
    MOLECULAR CYTOGENETICS, 2019, 12
  • [46] MUTATIONAL SIGNATURE AND CLONAL ARCHITECTURE OF LOW RISK MYELODYSPLASTIC SYNDROMES
    Adema, V.
    Palomo, L.
    Hirsch, C.
    Przychodzen, B.
    LaFramboise, T.
    Diez-Campelo, M.
    Nazha, A.
    Mallo, M.
    Xicoy, B.
    Carraway, H.
    Sekeres, M.
    Visconte, V.
    Sole, F.
    Maciejewski, J.
    LEUKEMIA RESEARCH, 2017, 55 : S5 - S5
  • [47] Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes
    Li, Xiao
    Wu, Lingyun
    Ying, Shaoxu
    Chang, Chunkang
    He, Qi
    Pu, Quan
    LEUKEMIA & LYMPHOMA, 2007, 48 (07) : 1353 - 1371
  • [48] Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Lhotska, Halka
    Svobodova, Karla
    Sarova, Iveta
    Lizcova, Libuse
    Izakova, Silvia
    Ransdorfova, Sarka
    Krejcik, Zdenek
    Belickova, Monika
    Siskova, Magda
    Jonasova, Anna
    Neuwirtova, Radana
    Zmolikova, Jana
    Cermak, Jaroslav
    BLOOD, 2014, 124 (21)
  • [49] Myelodysplastic syndromes: Review of pathophysiology and current novel treatment approaches
    Warlick, E. D.
    Smith, B. D.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (06) : 541 - 558
  • [50] Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy
    Zahid, Mohammad Faizan
    Patnaik, Mrinal M.
    Gangat, Naseema
    Hashmi, Shahrukh K.
    Rizzieri, David A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (04) : 313 - 320
12345